Pharmaceutical Patents and Monopolistic Pricing

South Africa’s struggle to increase access to anti-retroviral medications decades ago focused attention on the relationship between patent protection and high medicine prices. The COVID-19 pandemic has drawn greater attention to the cost of pharmaceutical technologies and the inequitable access to these. Globally this has raised concerns about the impact of the 1994 World Trade ...

Quamed logo Quality Medicine for all

Notice to QUAMED members and partners

Dear members, As we near our GA meeting set on the 9th June 2021, we’d like to kindly remind you all that it is crucial to check out our latest newsletter with the membership folder that includes all the important documents you’ll need for voting. As it is a statutory requirement, be sure to check it ...

Social and ethical issues of poor quality and misuse of medical products: a special issue of BMJ Global Health

We are pleased to share with you the link to the first articles recently published on BMJ Global Health on ‘The social and ethical problems of poor quality and misuse of medical products’   (https://gh.bmj.com/content/6/Suppl_3/) This issue includes a “hands-on” manuscript by Katherine Enright: Elusive quality: the ethical challenges and dilemmas facing international non-governmental organizations in the ...

Fighting poor quality health products in times of Covid-19 and beyond: the need for a multi-stakeholder approach

World Health Organization (WHO) estimates from 2017 indicates that 10.5% of medical products available in low- and middle-income countries (LMICs) are “substandard or falsified” (SF). Substandard health products are approved by the national regulators, but they do not comply with adequate standards due to undetected errors, negligence, or poor practice in manufacturing, transportation, or storage. ...

Collaboration of Quamed with Mauritanian Health Ministry

Jean-Christophe Pelissier meets with Minister of Health Minister Hon. Dr. Mohamed Nedhirou Hamed in the light of our collaboration to introduce good pharmaceutical practices in Mauritania. This will be done through: Phase 1: An inventory of private and public wholesalers based on the WHO MQAS and BPDS guidelines Phase 2: A proposal for specifications that ...

Fighting poor-quality health products in times of COVID19 and beyond

Dear Colleagues and Friends, To prevent, detect and combat poor-quality health products, it is urgent to strengthen the collaboration and synergies between the different stakeholders, and in particular regulators and law enforcement authorities. I am happy to inform you that Belgium organizes, in the frame of the 30th session of the Commission on Crime Prevention and Criminal Justice (CCPCJ), with the support of UNODC, ...

Rafaella’s Literature Update

Be-cause Health & QUAMED literature updates ·         Ref. Bourasseau, A., Lavergne, L. & Ravinetto, R. Assessments of the quality systems of pharmaceutical distributors: a remote approach to be applied in times of COVID-19 and beyond. J of Pharm Policy and Pract 2021; 14, 43 Dear Friend, Today, I would like to present a very recent publication, which just appeared in ...

Covid-19 vaccines patents interview

QUAMED member and ITM expert Raffaella Ravinetto was invited by TerZake, a Belgium/Flemish television news programme to talk about Covid-19 vaccines patents. “Some countries produce medicines. With adequate investment, they could also produce corona vaccines. Not for their own country – we don’t want vaccine nationalism – but for the region.” To see her interview, please ...

Would you like more information about audits or get a quote? Do not hesitate to contact us via the contact form.